COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say The comments were made in documents posted ahead of Thursday's meeting of a panel of FDA's independent experts, who are expected to make recommendations on what strain an updated COVID-19 booster should target. https://ift.tt/inJrgdT